D. De Wolf
Vrije Universiteit Brussel
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by D. De Wolf.
Acta Paediatrica | 1993
Stefaan Peeters; Yvan Vandenplas; Kristin Jochmans; Adel Bougatef; Marc De Waele; D. De Wolf
We report the case of a newborn girl with antithrombin III deficiency type 1. The clinical features of a hypercoagulable condition that lead to this rare diagnosis differed from the reports in the literature, since the primary thromboembolic incident resulted in neonatal myocardial infarction, which is in itself a rare condition during the first days of life.
Pediatric Cardiology | 1994
D. De Wolf; M. Terriere; P. De Wilde; J. F. Reidy
SummaryCongenital coronary artery disorders are rare. Elective closure is proposed in view of the morbidity reported later in life. Excellent results have been reported with surgery, and recently catheter occlusions have been successful. We report the case of a 2-year-old girl whose coronary artery fistula was occluded with a special controlled delivery coil system.
European Journal of Pediatrics | 1994
D. De Wolf; Gilles Rondia; Henri Verhaaren; Dirk Matthys
Adenosine is an endogenous nucleoside acting on coronary perfusion and myocardial conduction. Although the anti-arrhythmic effects of adenosine have been known for decades, interest in the use of adenosine or adenosine-tri-phosphate (ATP) (a precursor of adenosine) in termination of supraventricular tachycardia (SVT) has been renewed. We studied the use of striadyne (ATP and a mixture of other nucleosides including adenosine) in 22 infants younger than 6 months in order to evaluate efficiency and safety of the drug in this particular age group. Striadyne stopped SVT in 17 cases and was diagnostic in another 4 cases. Ten out of 17 successfully converted infants showed one or more reinitiations of SVT, which were easily controlled. The results support the efficiency of ATP for the termination of re-entry types of tachycardia, as well as its diagnostic value and its lack of serious side-effects.There could be a role for adenosine or ATP for safe termination of most cases of SVT in infancy before transferring these infants to a specialised paediatric cardiology department.
Medicine and Science in Sports and Exercise | 1994
Paul Dendale; Kenny De Meirleir; D. De Wolf
We report the case of a young boy on routine sports medical examination, who presented an incessant atrial tachycardia. At the slightest exercise the ventricular rhythm accelerated to 160 beats.min-1. Exercise capacity was excellent, and a treatment with propafenone suppressed the tachyarrhythmia.
European Journal of Pediatrics | 1989
D. De Wolf; F. Keuppens; M. Temmerman; M. Verboven; Michel Deneyer; M. Delree; L. Sacre-Smits
The suspected diagnosis of urological disorders made on the basis of antenatal ultrasonography was compared with the final outcome in 23 cases. In 18 cases the initial diagnosis could be confirmed, whereas 5 showed no postnatal urological anomalies. Further efforts should be undertaken to improve prenatal diagnosis in order to facilitate treatment as early as possible.
Pediatrics | 1986
Yvan Vandenplas; D. De Wolf; Liliane Sacre
Prenatal Diagnosis | 1994
Luc De Catte; D. De Wolf; Johan Smitz; Adel Bougatef; Jean De Schepper; Walter Foulon
American Journal of Perinatology | 1993
J. De Schepper; Said Hachimi-Idrissi; B. Cham; Adel Bougatef; D. De Wolf; B. Desprechins; Liliane Sacre
European Journal of Pediatrics | 1994
D. De Wolf; G. Rondia; Henri Verhaaren; Dirk Matthys
Acta Cardiologica | 1994
D. De Wolf; M. S. J. Naeff; G. Losekoot